Matthew T. Roe, MD, MHS

Original Contribution

Differential Longitudinal Outcomes Following Percutaneous Coronary Intervention to the Left Internal Mammary Artery and Other Bypass Grafts of the LAD: Findings From the NCDR

05/30/2020

Pearl Zakroysky , MPH;

David Dai , MPH;

Matthew T. Roe , MD, MHS;

Reginald Low , MD;

Daniel Wojdyla , MS;

Kendrick A. Shunk , MD, PhD;

Keong Keong Yeo , MBBS;

Farnaz Azarbal , MD;

Limited studies of percutaneous coronary intervention (PCI) of the left internal mammary artery (LIMA) graft exist. The authors compared outcomes of different bypass grafts to the left anterior descending (LAD) coronary artery.

Limited studies of percutaneous...

05/30/2020

Journal of Invasive Cardiology

Integrating GP IIb/IIIa Inhibition into Treatment Strategies for Acute ST-Elevation Myocardial Infarction (Part II)

08/01/2008

Matthew T. Roe , MD, MHS;

David E. Kandzari , MD;

“Facilitated fibrinolysis”: GP IIb/IIIa inhibitors and fibrinolytic therapy in ST-elevation infarction. Considering the abundant platelet-rich thrombus present in almost all patients with acute myocardial infarction, it is intuitive that...

“Facilitated fibrinolysis”: GP...

08/01/2008

Journal of Invasive Cardiology

Integrating GP IIb/IIIa Inhibition into Treatment Strategies for Acute ST-Elevation Myocardial Infarction (PART I)

08/01/2008

David E. Kandzari , MD;

Matthew T. Roe , MD, MHS;

Overview. Against the background of established clinical benefit in non-ST segment elevation acute coronary syndromes (ACS) and elective percutaneous revascularization, recent trials examining the role of glycoprotein (GP) IIb/IIIa inhibition...

Overview. Against the background...

08/01/2008

Journal of Invasive Cardiology

Prasugrel in UA/NSTEMI Patients: The Implications of TRILOGY ACS

11/06/2012

Matthew T. Roe , MD, MHS;

Performed at 966 sites in 52 countries, TRILOGY ACS (TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes) was a double-blind, randomized trial in which the effect of prasugrel was compared...

Performed at 966 sites in 52...

11/06/2012

Cath Lab Digest